Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.21.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation

9. Stock-Based Compensation

 

A summary of the Company’s outstanding stock option activity for the three months ended March 31, 2021 and 2020 is as follows:

 

 

          March 31, 2021        
         

Weighted-

Average

   

Weighted-

Average

Remaining

Contractual Life

    Intrinsic  
    Options     Exercise Price     (Years)     Value  
As of December 31, 2020     465,393     $ 5.53       9.3       -  
Granted     368,500       1.93       10.0       -  
Exercised     -       -       -       -  
Forfeited     -       -       -       -  
Expired     -       -       -       -  
As of March 31, 2021     833,893     $ 3.98       9.4     $ 698,913  
Exercisable at March 31, 2021     376     $ 6,977.42       4.1     $ -  
Vested and expected to vest at March 31, 2021     833,893     $ 3.98       9.4     $ 698,913  

 

          March 31, 2020        
         

Weighted-

Average

   

Weighted-

Average

Remaining

Contractual Life

    Intrinsic  
    Options     Exercise Price     (Years)     Value  
As of December 31, 2019     377     $ 7,446.69       5.3     $ -  
Granted     -       -       -       -  
Exercised     -       -       -       -  
Forfeited     -       -       -       -  
Expired     -       -       -       -  
As of March 31, 2020     377     $ 7,446.69       5.1     $ -  
Exercisable and vested at March 31, 2020     377     $ 7,446.69       5.1     $ -  

 

The Company estimates the fair value of each stock option on the grant date using the Black-Scholes-Merton valuation model, which requires several estimates including an estimate of the fair value of the underlying common stock on grant date. The expected volatility was based on an average of the historical volatility of the Company. The expected term was contractual life of option. The risk-free interest rate was based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the option. The following weighted average assumptions were used in the calculation to estimate the fair value of options granted to employees and non-employees during the three months ended March 31, 2021. During the three months ended March 31, 2021 the company granted stock options with an estimated fair value of approximately $0.6  million.

 

    March 31, 2021  
Weighted-average risk-free interest rate     0.73%-0.85 %
Weighted-average expected life (in years)     5.3-5.9  
Expected dividend yield     - %
Weighted-average expected volatility     138%-139 %

 

Of the 368,500 options granted during the three months ended March 31, 2021, 60,000  were to non-executive members of the board of directors. Of the 833,893 options outstanding as of March 31, 2021, 295,000  were awarded to non-executive members of the board of directors.

 

Unrecognized stock-based compensation  as of March 31, 2021, is as follows (in thousands):

 

         

Weighted

Average

 
   

Unrecognized

Stock-Based

   

Remaining of

Recognition

 
    Compensation     (in years)  
Stock options   $ 779       2.5  
Stock grants   $ 17       2.1